Your session is about to expire
← Back to Search
Practice E for Papillomavirus Vaccines
Study Summary
This trial will test different ways to get more people to vaccinate against HPV, which causes 30,000 cancers in the US each year.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
How many participants are taking part in this clinical experiment?
"Indeed, the information presented on clinicaltrials.gov affirms that this trial is actively searching for participants; it was initially posted in April of 2018 and has since been updated at the end of July 2022. The research group aims to recruit 10,000 individuals from a single site."
Does this medical research include participants who are in their mid-fifties or older?
"As stated in the study's inclusion critiera, only participants between the ages of 11 and 12 may be enrolled."
Is there still availability for participants in this trial?
"According to current information provided by clinicaltrials.gov, this medical research is actively recruiting volunteers. The trial was initiated on April 1st 2018 and has undergone its most recent update on July 28th 2022."
What qualities make individuals the ideal candidates for this clinical experiment?
"This medical study will recruit 10000 children aged 11-12 who have already received papillomavirus vaccines. These participants need to meet additional criteria, such as having been administered at least one dose of the HPV vaccine over a 12 month period and being registered in one of six primary care practices. It is also essential that they are between eleven and twelve years old when the trial commences."
Share this study with friends
Copy Link
Messenger